Related Experiment Video
Updated: Aug 9, 2026
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Hypericum treatment of mild depressions with somatic symptoms
W D Hübner1, S Lande, H Podzuweit
1Lichtwer Pharma GmbH, Berlin, Germany.
Insights
Hypericum extract LI 160 significantly improved depression with somatic symptoms in a 4-week trial. Most patients experienced symptom relief with no adverse effects, highlighting its efficacy and safety.
Area of Science:
- Psychiatry
- Pharmacology
- Herbal Medicine
Background:
- Depression with somatic symptoms presents a significant clinical challenge.
- Standard treatments may have limitations or side effects.
- Herbal remedies are increasingly explored for mood disorders.
Purpose of the Study:
- To evaluate the efficacy and safety of Hypericum extract LI 160 in patients with depression and somatic symptoms.
- To compare the effects of Hypericum extract LI 160 against a placebo.
Main Methods:
- A randomized, placebo-controlled, double-blind study was conducted over 4 weeks.
- 39 patients with depression and somatic symptoms received either Hypericum extract LI 160 (300 mg TID) or placebo.
- Symptom assessment included HAMD, B-L, CGI, and vegetative symptoms at baseline and weeks 2 and 4.
Main Results:
- The Hypericum extract group showed statistically significant improvement compared to placebo (p<0.05).
- Seventy percent of patients on LI 160 achieved symptom remission after 4 weeks.
- Key depressive symptoms like fatigue, tiredness, and sleep disturbances responded well.
Conclusions:
- Hypericum extract LI 160 is an effective and safe treatment option for depression with somatic symptoms.
- The extract demonstrates a favorable side effect profile.
- Further research into herbal interventions for somatic depression is warranted.
Abstract:
In a randomized, placebo-controlled, double-blind study, 39 patients with depression with somatic symptoms were treated with hypericum extract LI 160. The therapy lasted for 4 weeks; the dosage was 300 mg three times daily. At the onset of the study as well as after 2 and 4 weeks, the following criteria were analyzed: HAMD, B-L, CGI, and vegetative symptoms. The results show a significant improvement in the active treatment group at the 5% level as compared to placebo. Seventy percent of the patients treated with LI 160 were free of symptoms after 4 weeks. Typical symptoms of the depression such as lack of activity, tiredness, fatigue, and disturbed sleep, were especially responsive. In no case were any undesirable side effects observed.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
01:25Antidepressant Drugs: Overview
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
01:23Antidepressant Drugs: MAOIs and Other Agents
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...